Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Ischemic Heart Disease

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 376 articles:
HTML format



Single Articles


    April 2026
  1. STEPANIAN A, Jaffe IZ
    Response by Stepanian and Jaffe to Letters Regarding Article, "Ponatinib, but Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Inf
    Circulation. 2026;153:e1113-e1114.
    PubMed    


  2. ZHENG T, Yuan X, Liu H
    Letter by Zheng et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1109-e1110.
    PubMed    


  3. XU X, Zhang S, Bao L
    Letter by Xu et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1111-e1112.
    PubMed    


  4. LIU C, Li X
    Letter by Liu and Li Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1107-e1108.
    PubMed    


  5. SCHRAMA TJ, Aengevaeren VL
    Disentangling the Relationship Between Exercise and Coronary Atherosclerosis: Wearable Training Data Are the Way Forward.
    Circulation. 2026;153:1023-1025.
    PubMed    


  6. KUYUCU I, Canavar OF, Dogruer RD, Altin AD, et al
    Correction to: Abstract 4367615: The Cardiovascular Paradox of Gout Prophylaxis: A Systematic Review and Meta-analysis.
    Circulation. 2026;153:e1116.
    PubMed    


  7. HOJBJERG LASSEN MC, Ostrominski JW, Claggett BL, Ndumele CE, et al
    Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.
    Circulation. 2026 Apr 1. doi: 10.1161/CIRCULATIONAHA.125.077894.
    PubMed     Abstract available


    March 2026
  8. LI L
    Myocardial Infarction, Precision-Engineered T Regulatory Cells to the Rescue.
    Circulation. 2026;153:998-1000.
    PubMed    


  9. ZHANG M, Qin Y, Zhou T, Liu M, et al
    Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair.
    Circulation. 2026;153:983-997.
    PubMed     Abstract available


  10. LICHTENSTEIN AH, Khera A, Anderson CAM, Appel LJ, et al
    2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Mar 31. doi: 10.1161/CIR.0000000000001435.
    PubMed     Abstract available


  11. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Correction to: Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026;153:e1106.
    PubMed    


  12. BELLAVIA A, Murphy SA
    Competing Risks in Cardiovascular Research: A Practical Perspective.
    Circulation. 2026;153:945-947.
    PubMed    


  13. HUNDEMER GL, Vaidya A
    Response by Hundemer and Vaidya to Letter Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
    Circulation. 2026;153:e1053-e1054.
    PubMed    


  14. XU J, Sun Y
    Letter by Xu and Sun Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
    Circulation. 2026;153:e1052.
    PubMed    


  15. VEMULAPALLI S, Pena Guerra K, Wojdyla D, Jones WS, et al
    Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080072.
    PubMed     Abstract available


  16. MARSTON NA, Bergmark BA, Prohaska TA, Moura FA, et al
    Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080012.
    PubMed     Abstract available


  17. HANNEMAN K, Alahmad B, Ghosh A, Khatana SAM, et al
    Nonoptimal Temperature and Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Mar 26. doi: 10.1161/CIR.0000000000001419.
    PubMed     Abstract available


  18. SUN S, Zhang X, Yue H, Fan C, et al
    The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis.
    Circulation. 2026;153:902-921.
    PubMed     Abstract available


  19. DENG KQ, Xu Z, Wang Q, Cai HH, et al
    Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction.
    Circulation. 2026;153:826-844.
    PubMed     Abstract available


  20. DHRUVA SS
    Role of High-Dose Influenza Vaccine in Reducing Cardiovascular Risk.
    Circulation. 2026;153:807-809.
    PubMed    


  21. WATSON KE, Fonarow GC
    The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment.
    Circulation. 2026 Mar 13. doi: 10.1161/CIRCULATIONAHA.126.079538.
    PubMed    


  22. ZHU X, Li W, Yu J
    Letter by Zhu et al Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
    Circulation. 2026;153:e913.
    PubMed    


  23. CHU L, Ma X, Chen K
    Response by Chu et al to Letter Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
    Circulation. 2026;153:e914-e915.
    PubMed    


  24. ARAIZA-GARAYGORDOBIL D, Garcia-Jimenez Y, Gopar-Nieto R
    Global Rounds Mexico: Improving Cardiovascular Health Through Integration.
    Circulation. 2026;153:696-698.
    PubMed    


  25. HE J, Zhu Y
    Correction to: Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:e909.
    PubMed    


  26. JARR KU, Peters A, Leeper NJ
    Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.
    Circulation. 2026;153:613-615.
    PubMed    


    February 2026
  27. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 25. doi: 10.1161/CIR.0000000000001406.
    PubMed     Abstract available


  28. XIE J, Cheng LM, Liu K
    Letter by Xie et al Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e109-e110.
    PubMed    


  29. HUANG J, Fogacci F
    Letter by Huang and Fogacci Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e111-e112.
    PubMed    


  30. BERRY JD, Leonard D, Levine BD, DeFina LF, et al
    Response by Berry et al to Letter Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e113-e114.
    PubMed    


  31. CARNETHON MR, Post WS, Hill JA, Al-Khatib SM, et al
    Go(ing) Red for Women and Fulfilling Our Commitment to Sex-Based Reporting of Cardiovascular Disease.
    Circulation. 2026;153:467-468.
    PubMed    


  32. GRAGNANO F, Giacoppo D, Choi KH, Kimura T, et al
    Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials.
    Circulation. 2026;153:543-546.
    PubMed    


  33. ROSEN SE
    Redefining Cardiovascular Medicine: The Journey From "Does Sex Matter?" to "How Does Sex Matter?".
    Circulation. 2026;153:534-535.
    PubMed    


  34. BOYER TM, Barrett RB, Xiong C, Bu F, et al
    Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women.
    Circulation. 2026;153:480-492.
    PubMed     Abstract available


  35. LI N, Hao Z, Yang H, Cai J, et al
    CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.076426.
    PubMed     Abstract available


  36. DARDARI ZA, Yao Z, Zhang J, Bakoyannis G, et al
    Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration.
    Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.075327.
    PubMed     Abstract available


  37. BAI X, Ren R, Yuan J, Yu L, et al
    Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1.
    Circulation. 2026 Feb 11. doi: 10.1161/CIRCULATIONAHA.125.076101.
    PubMed     Abstract available


  38. KHAN SS, Greenland P, Hayman LL, Khera R, et al
    Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 11. doi: 10.1161/CIR.0000000000001401.
    PubMed     Abstract available


  39. MADHAVAN MV, Gregson J, Redfors B, Chen S, et al
    Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial.
    Circulation. 2026 Feb 10. doi: 10.1161/CIRCULATIONAHA.125.075875.
    PubMed     Abstract available


  40. ZHAO L, Zhao C, Wang Y
    Letter by Zhao et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e71-e72.
    PubMed    


  41. HUANG Q, Jian X, Wu F
    Letter by Huang et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e69-e70.
    PubMed    


  42. WU Y, Nguyen T, Wang Y, Zhou Y, et al
    Cardiomyocyte-Specific modRNA-Induced FoxM1 Overexpression Promotes Recovery From Myocardial Infarction in Adult Mammals.
    Circulation. 2026;153:463-466.
    PubMed    


  43. RHEE JW, Bolton KL, Gupta D, Weeks LD, et al
    Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 10. doi: 10.1161/CIR.0000000000001404.
    PubMed     Abstract available


  44. VON HUNDELSHAUSEN P, Siess W, Duan R, Bohnert T, et al
    Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting.
    Circulation. 2026;153:435-456.
    PubMed     Abstract available


  45. ZHANG L, Iliescu C, Ferencik M, Finamore V, et al
    Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 9. doi: 10.1161/CIR.0000000000001391.
    PubMed     Abstract available


  46. LI X, Li X, Li CX, Feng J, et al
    TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn(2+) Homeostasis.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.125.074791.
    PubMed     Abstract available


  47. BANGALORE S, Fearon WF, Fugar S, Dangas GD, et al
    Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association.
    Circulation. 2026;153:e25-e41.
    PubMed     Abstract available


  48. KOVACIC JC, Reynolds HR, Alasnag M, Blakeman JR, et al
    Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 3. doi: 10.1161/CIR.0000000000001416.
    PubMed     Abstract available


    January 2026
  49. PAUWELS R, Dausin C, Ruiz-Carmona S, De Bosscher R, et al
    Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study.
    Circulation. 2026 Jan 29. doi: 10.1161/CIRCULATIONAHA.125.077117.
    PubMed     Abstract available


  50. CHANG Q, Li C, Xu Z
    An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization.
    Circulation. 2026;153:282-284.
    PubMed    


  51. ARMSTRONG A, Pugh D, Basu N, Dhaun N, et al
    Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
    Circulation. 2026;153:266-281.
    PubMed     Abstract available


  52. CHO Y, Kang D, Lim H, Lee H, et al
    Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study.
    Circulation. 2026 Jan 23. doi: 10.1161/CIRCULATIONAHA.125.078919.
    PubMed     Abstract available


  53. HE J, Zhu Y
    Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:185-188.
    PubMed    


  54. PYRPYRIS N, Dimitriadis K, Tsioufis K
    Letter by Pyrpyris et al Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e14-e15.
    PubMed    


  55. MAENG M, Thrane PG, Erlinge D, Maehara A, et al
    Response by Maeng et al to Letters Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e17-e18.
    PubMed    


  56. SUN P
    Letter by Sun Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e16.
    PubMed    


  57. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Correction to: Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2026;153:e19.
    PubMed    


  58. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
    Circulation. 2026 Jan 20. doi: 10.1161/CIRCULATIONAHA.125.079034.
    PubMed     Abstract available


  59. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Correction to: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2026;153:e11.
    PubMed    


  60. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Response by Sittichokkananon et al to Letter Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e6-e7.
    PubMed    


  61. YANG S, Lu Y
    Letter by Yang and Lu Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e4-e5.
    PubMed    


  62. ZHAO YT
    Letter by Zhao Regarding Article, "Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial".
    Circulation. 2026;153:e8-e9.
    PubMed    


  63. FEARON WF, Terada K, Takahashi K, Skoda A, et al
    Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial.
    Circulation. 2026;153:7-17.
    PubMed     Abstract available


  64. LEONARDI S, Landi A, Zito A, Branca M, et al
    Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
    Circulation. 2026 Jan 6. doi: 10.1161/CIRCULATIONAHA.125.077174.
    PubMed     Abstract available


    December 2025
  65. GUNAWARDENE MA, Schmidt B, Peichl P, Nair D, et al
    Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After Pulsed Field Ablation of Atrial Fibrillation.
    Circulation. 2025 Dec 25. doi: 10.1161/CIRCULATIONAHA.125.077983.
    PubMed    


  66. HENRIKSEN PA
    Challenges of Clinical Trials in Cardio-Oncology: Navigating Surrogate Outcomes and Identifying Patients at Risk of Late Cardiovascular Complications.
    Circulation. 2025;152:1756-1758.
    PubMed    


  67. TRAN AH, Zaidi AH, Bolger AF, Del Brutto OH, et al
    Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 16. doi: 10.1161/CIR.0000000000001390.
    PubMed     Abstract available


  68. XU L, Hrybouski S, Liao TE, Dong JN, et al
    Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
    Circulation. 2025;152:1608-1620.
    PubMed     Abstract available


  69. SHARIF A
    Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk-Reducing Intervention in Kidney Failure.
    Circulation. 2025;152:1591-1593.
    PubMed    


  70. TOMCZYK M, Kraszewska I, Li G, Hayes MJ, et al
    Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction.
    Circulation. 2025;152:1586-1589.
    PubMed    


  71. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Chotai S, et al
    The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
    Circulation. 2025;152:1541-1551.
    PubMed     Abstract available


  72. FETTERMAN JL, Chinnery PF, McClellan R, Wallace DC, et al
    Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 2. doi: 10.1161/CIR.0000000000001393.
    PubMed     Abstract available


  73. TSIMIKAS S, Szarek M, Cobbaert CM, Romijn F, et al
    Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome.
    Circulation. 2025 Dec 1. doi: 10.1161/CIRCULATIONAHA.125.073855.
    PubMed     Abstract available


    November 2025
  74. CHEN Y
    Letter by Chen Regarding Article, "Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality".
    Circulation. 2025;152:e407.
    PubMed    


  75. TULETA I, Venugopal H, O'Leary K, Zheng D, et al
    Fibroblast-Specific Loss of TGF-beta Signaling Mediates Lipomatous Metaplasia in the Infarcted Heart.
    Circulation. 2025;152:1423-1435.
    PubMed     Abstract available


  76. DAMLUJI AA, Nanna MG, Mason P, Lowenstern A, et al
    Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 18. doi: 10.1161/CIR.0000000000001387.
    PubMed     Abstract available


  77. LANDSTROM AP, Ferguson JF, James CA, Key KV, et al
    Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association.
    Circulation. 2025 Nov 13. doi: 10.1161/CIR.0000000000001385.
    PubMed     Abstract available


  78. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;152:e402.
    PubMed    


  79. OHAYON-STECKEL L, Zhang X, Haque S, Uddin MA, et al
    miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.124.073527.
    PubMed     Abstract available


  80. DUDUM R, Jain SS, Mastrodicasa D, Furst A, et al
    Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription: the NOTIFY-PICTURE Trial.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.078155.
    PubMed    


  81. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
    High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.077801.
    PubMed     Abstract available


  82. SLIPCZUK L, Blankstein R, Bucciarelli-Ducci C, Braun LT, et al
    State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 10. doi: 10.1161/CIR.0000000000001394.
    PubMed     Abstract available


  83. LEMESLE G, Didier R, Diallo A, Dromas H, et al
    Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical Trials.
    Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.077141.
    PubMed    


  84. RAPOSEIRAS ROUBIN S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al
    Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
    Circulation. 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.
    PubMed     Abstract available


  85. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Correction to: Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025;152:e371.
    PubMed    


    October 2025
  86. RUEL M
    Introduction to the 2025 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2025;152:1187.
    PubMed    


  87. DONOGHUE AJ, Auerbach M, Banerjee A, Blewer AL, et al
    Part 12: Resuscitation Education Science: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  88. HIRSCH KG, Amorim E, Coppler PJ, Drennan IR, et al
    Part 11: Post-Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  89. DEL RIOS M, Bartos JA, Panchal AR, Atkins DL, et al
    Part 1: Executive Summary: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  90. PANCHAL AR, Bartos JA, Wyckoff MH, Drennan IR, et al
    Part 2: Evidence Evaluation and Guidelines Development: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  91. JOYNER BL JR, Dewan M, Bavare A, de Caen A, et al
    Part 6: Pediatric Basic Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  92. ELMER J, Atkins DL, Daya MR, Del Rios M, et al
    Part 3: Ethics: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  93. CAO D, Arens AM, Chow SL, Easter SR, et al
    Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  94. KLEINMAN ME, Buick JE, Huber N, Idris AH, et al
    Part 7: Adult Basic Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  95. LEE HC, Strand ML, Finan E, Illuzzi J, et al
    Part 5: Neonatal Resuscitation: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  96. DEZFULIAN C, Cabanas JG, Buckley JR, Cash RE, et al
    Part 4: Systems of Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  97. LASA JJ, Dhillon GS, Duff JP, Hayes J, et al
    Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  98. WIGGINTON JG, Agarwal S, Bartos JA, Coute RA, et al
    Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    PubMed     Abstract available


  99. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Andersen JT, et al
    Response by Windfeld-Mathiasen et al to Letter Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
    Circulation. 2025;152:e296-e297.
    PubMed    


  100. KING SJ, Furst A, Fan J, Chen TP, et al
    Comparison of the Pooled Cohort and the PREVENT Cardiovascular Disease Risk Equations in the Veterans Health Administration.
    Circulation. 2025;152:1183-1185.
    PubMed    


  101. KORNELIUS E
    Letter by Kornelius Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
    Circulation. 2025;152:e295.
    PubMed    


  102. KOLE A, Joshi PH
    Clear as Mud: Determining the Stage of Prevention in Cardiovascular Disease.
    Circulation. 2025;152:1123-1125.
    PubMed    


  103. REGAN JA, Laitner MH, Dzau VJ
    A Crossroads in Cardiovascular Medicine: Progress and Barriers to Impact.
    Circulation. 2025;152:1166-1173.
    PubMed     Abstract available


  104. CHEN X, Yu X, Zhong S, Sha P, et al
    ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury.
    Circulation. 2025 Oct 20. doi: 10.1161/CIRCULATIONAHA.125.075220.
    PubMed     Abstract available


  105. FORAKER R, Sperling L, Bratzke L, Budoff M, et al
    Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Oct 16. doi: 10.1161/CIR.0000000000001382.
    PubMed     Abstract available


  106. KHAN SS, Fisher SA
    Bending the Curve in Maternal Mortality: Pregnancy as a Moment for Cardiovascular Disease Prevention.
    Circulation. 2025;152:1056-1059.
    PubMed    


  107. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2025;152:1044-1055.
    PubMed     Abstract available


  108. OREN O, Libby P
    Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice.
    Circulation. 2025;152:975-977.
    PubMed    


    September 2025
  109. VONGPATANASIN W, Abraham J, Giacona JM
    Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?
    Circulation. 2025;152:924-926.
    PubMed    


  110. SECHI LA, Bulfone L, Catena C
    Letter by Sechi et al Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e265-e266.
    PubMed    


  111. BHATIA HS, Tsimikas S
    Response by Bhatia and Tsimikas to Letter Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e267-e268.
    PubMed    


  112. PETEK BJ, Churchill TW, Moulson N, Baggish AL, et al
    Sudden Cardiac Arrest and Death Secondary to Congenital Coronary Artery Abnormalities in Young Competitive Athletes.
    Circulation. 2025;152:971-973.
    PubMed    


  113. GENTILE F, Carapellucci E, Uggenti V, Lorenzoni V, et al
    Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074198.
    PubMed     Abstract available


  114. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
    Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
    PubMed     Abstract available


  115. GAN J, Zhao R, Zheng D, Peng Y, et al
    PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.
    Circulation. 2025 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.072312.
    PubMed     Abstract available


  116. FENG S, Wang Z, Sun R
    Letter by Feng et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e239-e240.
    PubMed    


  117. ZHONG Y, Lai R, Deng X
    Letter by Zhong et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e241-e242.
    PubMed    


  118. JI Y, Chen LY, Zhang MJ
    Response by Ji et al to Letters Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e243-e244.
    PubMed    


  119. LEVINE GN, Carney RM, Cohen BE, Dunn SL, et al
    Post-Myocardial Infarction Psychological Distress: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Sep 22. doi: 10.1161/CIR.0000000000001381.
    PubMed     Abstract available


  120. COUTINHO T
    The Geometry of Aging: New Angles on Cardiovascular Risk.
    Circulation. 2025;152:762-764.
    PubMed    


  121. HUDED CP, Spertus JA, Jones PG, O'Brien SM, et al
    Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
    Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.073591.
    PubMed     Abstract available


  122. SHI F, Zheng B, Liu Y
    Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e71-e72.
    PubMed    


  123. NAMBI V, de Lemos JA, Ballantyne CM
    A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
    Circulation. 2025;152:567-569.
    PubMed    


  124. KUEHN BM
    Microplastics Exposure Linked to Cardiovascular Disease Risk, Chronic Health Conditions.
    Circulation. 2025;152:630-631.
    PubMed    


  125. SILBERNAGEL G, Wen Y, Konrad RJ
    Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e73-e74.
    PubMed    


  126. HUANG J
    Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e69-e70.
    PubMed    


  127. CROON PM, Dhingra LS, Biswas D, Oikonomou EK, et al
    Phenotypic Selectivity of Artificial Intelligence-enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.
    Circulation. 2025 Sep 1. doi: 10.1161/CIRCULATIONAHA.125.076279.
    PubMed     Abstract available


    August 2025
  128. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
    PubMed     Abstract available


  129. CHEN BY, Zhu H, Li YL, Zhang J, et al
    Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells.
    Circulation. 2025 Aug 27. doi: 10.1161/CIRCULATIONAHA.125.074837.
    PubMed     Abstract available


  130. WU J, Zheng Y
    Letter by Wu and Zheng Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e67.
    PubMed    


  131. HO FK, Sattar N, Welsh P
    Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e68.
    PubMed    


  132. QIN D, Modanwal R, Ghazi M, Corbalan JJ, et al
    Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.
    Circulation. 2025;152:486-488.
    PubMed    


  133. BERRY C, Carberry J, Dharmakumar R
    Intramyocardial Hemorrhage After Myocardial Infarction: A Prognostic Outcome for Clinical Practice and Trials.
    Circulation. 2025;152:349-351.
    PubMed    


  134. VIDOT DC
    Up in Smoke: No Association Between Cannabis Smoking and Cardiovascular Events Among Older Military Veterans With Coronary Artery Disease.
    Circulation. 2025;152:366-368.
    PubMed    


  135. LAWN RB, Murchland AR, Thurston RC, Marquez C, et al
    Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.
    Circulation. 2025 Aug 11:10.1161/CIRCULATIONAHA.124.073592.
    PubMed     Abstract available


  136. STEPANIAN A, Travers RJ, Tesfu A, Wolter NL, et al
    Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
    Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.073610.
    PubMed     Abstract available


  137. BECKMAN JA, Drooz AT, Farber A, Hamdan A, et al
    The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
    Circulation. 2025;152:346-348.
    PubMed    


  138. TABAK RG, Kandula NR, Angell SY, Brewer LC, et al
    Implementation of Evidence-Based Behavioral Interventions for Cardiovascular Disease Prevention in Community Settings: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Aug 4. doi: 10.1161/CIR.0000000000001349.
    PubMed     Abstract available


    July 2025
  139. WERESKI R, Morrow DA, Mills NL
    Unstable Angina Refined.
    Circulation. 2025;152:213-216.
    PubMed    


  140. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
    CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Circulation. 2025;152:257-273.
    PubMed     Abstract available


  141. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025 Jul 25. doi: 10.1161/CIRCULATIONAHA.125.073937.
    PubMed     Abstract available


  142. KEYHANI S, Cohen BE, Vali M, Hoggatt KJ, et al
    Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.
    Circulation. 2025 Jul 21. doi: 10.1161/CIRCULATIONAHA.124.073193.
    PubMed     Abstract available


  143. CARBONNEAU M, Li Y, Qu Y, Zheng Y, et al
    DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases.
    Circulation. 2025 Jul 14:10.1161/CIRCULATIONAHA.124.073181.
    PubMed     Abstract available


  144. BANN GG, Dos Santos M, Chen K, Tan W, et al
    Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction.
    Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072733.
    PubMed     Abstract available


  145. GOUPIL R, Desbiens LC, Merabtine A, Agharazii M, et al
    Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.
    Circulation. 2025 Jul 9:10.1161/CIRCULATIONAHA.124.073507.
    PubMed     Abstract available


  146. HU Q, Zhang J, Luo X, Hu P, et al
    Intracellular L-PGDS-Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury.
    Circulation. 2025;152:41-57.
    PubMed     Abstract available


  147. HENDREN NS, Ammirati E
    Cardiovascular Effects of COVID-19: Legacy and Future Insights.
    Circulation. 2025;152:24-26.
    PubMed    


  148. CUEVAS C, Kikushima-Alcantara P, Miranda JJ
    The State of Cardiovascular Care in Peru: Needs for System Strengthening.
    Circulation. 2025;152:7-10.
    PubMed    


    June 2025
  149. GONG Y, Lu X, Wang X, Wang Y, et al
    Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
    Circulation. 2025 Jun 30. doi: 10.1161/CIRCULATIONAHA.124.069737.
    PubMed     Abstract available


  150. DUAN Z, Lin Z
    Response by Duan and Lin to Letter Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
    Circulation. 2025;151:e1093-e1094.
    PubMed    


  151. THRANE PG, Maeng M, Maehara A, Botker HE, et al
    Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.
    Circulation. 2025;151:1767-1779.
    PubMed     Abstract available


  152. WANG H, Zhao T, Zheng G
    Letter by Wang et al Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
    Circulation. 2025;151:e1091-e1092.
    PubMed    


  153. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e1098.
    PubMed    


  154. BELLAVIA A, Murphy SA
    Confounders, Effect Modifiers, and Mediators: Dealing With "Third Variables" in Cardiovascular Epidemiology.
    Circulation. 2025;151:1755-1757.
    PubMed    


  155. JOHNY E, Dutta P
    Targeting Extramedullary Hematopoiesis and Cardiac Immune Homing to Encourage Cardiac Healing After Myocardial Infarction.
    Circulation. 2025;151:1748-1751.
    PubMed    


  156. ARNAOUT R
    From Bytes to Beats: Overcoming Conceptual and Implementation Challenges for AI in Cardiovascular Care.
    Circulation. 2025;151:1697-1698.
    PubMed    


  157. GRECO M, Lombardi G, Brusasco C, Pieri M, et al
    Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial.
    Circulation. 2025 Jun 13. doi: 10.1161/CIRCULATIONAHA.125.075254.
    PubMed     Abstract available


  158. CAMPO G, Pavasini R
    Response by Campo and Pavasini to Letter Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1049-e1050.
    PubMed    


  159. PAN D, Wu W, Chen M
    Letter by Pan et al Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1047-e1048.
    PubMed    


  160. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jun 9. doi: 10.1161/CIR.0000000000001341.
    PubMed     Abstract available


  161. LEE S, Hwang SH, Park S, Son Y, et al
    Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.073086.
    PubMed     Abstract available


  162. OBEL LM, Skovbo JS, Diederichsen ACP, Thomassen M, et al
    Aortic Aneurysm Risk and Somatic JAK2(V617F)Variation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.074002.
    PubMed     Abstract available


  163. CHU L, Wang R, Gross CP, Wei J, et al
    Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States.
    Circulation. 2025 Jun 3. doi: 10.1161/CIRCULATIONAHA.124.073614.
    PubMed     Abstract available


  164. GREGSON J, Taylor D, Owen R, Collier T, et al
    Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance.
    Circulation. 2025;151:1606-1619.
    PubMed     Abstract available


    May 2025
  165. SCHNEEWEISS S, Kruger N
    Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
    Circulation. 2025;151:1495-1497.
    PubMed    


  166. BERRY C, McCartney P
    Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
    Circulation. 2025;151:e1002-e1003.
    PubMed    


  167. BULLUCK H, Hausenloy DJ
    Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
    Circulation. 2025;151:e1004-e1005.
    PubMed    


  168. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
    Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
    Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
    PubMed     Abstract available


  169. ZHANG Z, Yang X, Zhang Z
    Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e986-e987.
    PubMed    


  170. REITAN C, Andell P, Hofmann R, Jernberg T, et al
    Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e988-e989.
    PubMed    


  171. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025;151:e1000.
    PubMed    


  172. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
    The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
    Circulation. 2025;151:1430-1432.
    PubMed    


    April 2025
  173. CLARKE R, Wright N, Lin K, Yu C, et al
    Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
    Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
    PubMed     Abstract available


  174. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2025;151:e965-e966.
    PubMed    


  175. DONG J, Yang X, Zhang W
    Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e962-e963.
    PubMed    


  176. BONNESEN K, Heide-Jorgensen U, Schmidt M
    Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e964.
    PubMed    


  177. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
    Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
    PubMed     Abstract available


  178. LV H, Wang C, Liu Z, Quan M, et al
    Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
    PubMed     Abstract available


  179. BERRY JD, Zabad N, Kyrouac D, Leonard D, et al
    High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study.
    Circulation. 2025 Apr 21. doi: 10.1161/CIRCULATIONAHA.124.070335.
    PubMed     Abstract available


  180. GRAVEN LJ, Kitko L, Abshire Saylor M, Allen L, et al
    Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 17. doi: 10.1161/CIR.0000000000001323.
    PubMed     Abstract available


  181. STAMATAKIS E, Biswas RK, Koemel NA, Sabag A, et al
    Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality.
    Circulation. 2025;151:1063-1075.
    PubMed     Abstract available


  182. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316.
    PubMed     Abstract available


  183. CHEN Q, Zheng A, Xu X, Shi Z, et al
    Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2.
    Circulation. 2025;151:1024-1046.
    PubMed     Abstract available


  184. LAM NT, Nguyen NUN, Elhelaly WM, Hsu CC, et al
    Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility.
    Circulation. 2025;151:1009-1023.
    PubMed     Abstract available


  185. BENOWITZ NL
    Predicting Cardiovascular Risk With Use of Various Tobacco Products.
    Circulation. 2025;151:1006-1008.
    PubMed    


  186. STEG PG, Szarek M, Jukema JW, Bhatt DL, et al
    Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of O
    Circulation. 2025;151:1047-1050.
    PubMed    


  187. POWELL-WILEY TM, Brewer LC, Burke LE, Hernandez R, et al
    Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314.
    PubMed     Abstract available


  188. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
    Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
    PubMed     Abstract available


  189. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e865.
    PubMed    


  190. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025;151:e864.
    PubMed    


  191. YU M, Cheng X
    Response by Yu and Cheng to Letter Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e769-e770.
    PubMed    


  192. KAKIZAKI R, Raber L
    Letter by Kakizaki and Raber Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e767-e768.
    PubMed    


    March 2025
  193. MARX N, Deanfield JE, Mann JFE, Arechavaleta R, et al
    Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
    Circulation. 2025 Mar 29. doi: 10.1161/CIRCULATIONAHA.125.074545.
    PubMed     Abstract available


  194. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
    Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
    Circulation. 2025 Mar 28. doi: 10.1161/CIRCULATIONAHA.125.074517.
    PubMed    


  195. RYAN TD, Bates JE, Kinahan KE, Leger KJ, et al
    Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 19. doi: 10.1161/CIR.0000000000001308.
    PubMed     Abstract available


  196. NDUMELE CE, Ferdinand KC, Khan SS
    The Role of Race in Cardiovascular Disease Risk Prediction.
    Circulation. 2025;151:741-743.
    PubMed    


  197. HULL LE, Aday AW, Bui QM, Luzum JA, et al
    Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 13. doi: 10.1161/CIR.0000000000001304.
    PubMed     Abstract available


  198. KURAMITSU S, Kawase Y, Shinozaki T, Domei T, et al
    Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE Registry.
    Circulation. 2025;151:672-685.
    PubMed     Abstract available


  199. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Correction to: Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2025;151:e709.
    PubMed    


  200. CLAUDEL SE, Verma A
    Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.
    Circulation. 2025;151:716-732.
    PubMed     Abstract available


  201. ARUNOTHAYARAJ S, Egred M, Banning AP, Brunel P, et al
    Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.
    Circulation. 2025;151:612-622.
    PubMed     Abstract available


  202. KOU S, Lu Z, Deng D, Ye M, et al
    Activation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury.
    Circulation. 2025;151:623-639.
    PubMed     Abstract available


    February 2025
  203. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309.
    PubMed     Abstract available



  204. Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
    Circulation. 2025;151:e681.
    PubMed    



  205. Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018.
    Circulation. 2025;151:e680.
    PubMed    


  206. STARK AW, Matthey-de-l'Endroit RL, Ferroni A, Kakizaki R, et al
    Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study.
    Circulation. 2025;151:578-580.
    PubMed    


  207. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Feb 20. doi: 10.1161/CIR.0000000000001297.
    PubMed     Abstract available


  208. ARMILLOTTA M, Bergamaschi L, Paolisso P, Belmonte M, et al
    Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2025 Feb 19. doi: 10.1161/CIRCULATIONAHA.124.070729.
    PubMed     Abstract available


  209. NELLIPUDI JA, Kelly B, Hardikar A
    Addressing Cardiovascular Health Inequities in Indigenous Women: Insights from Australia and Global Perspectives.
    Circulation. 2025;151:427-429.
    PubMed    


  210. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Traerup Andersen J, et al
    Cardiovascular Disease in Anabolic Androgenic Steroid Users.
    Circulation. 2025 Feb 13. doi: 10.1161/CIRCULATIONAHA.124.071117.
    PubMed     Abstract available


  211. KIM SM, Kim S, Kim YJ, Kim WY, et al
    Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors.
    Circulation. 2025;151:421-423.
    PubMed    


  212. BRENNAN SO, Kelly PJ, Gorey S, Synnott P, et al
    Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.
    Circulation. 2025;151:334-336.
    PubMed    


    January 2025
  213. DAI J, Zhao J, Xu X, Chen Y, et al
    Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?
    Circulation. 2025 Jan 31. doi: 10.1161/CIRCULATIONAHA.124.071855.
    PubMed     Abstract available


  214. HALL EJ, Agarwal S, Cullum CM, Sinha SS, et al
    Survivorship After Cardiogenic Shock.
    Circulation. 2025;151:257-271.
    PubMed     Abstract available


  215. SINGER Z, Wijeysundera HC, Qiu F, Fang J, et al
    Driving Restrictions and Incapacitation Vulnerability Evaluation After ST-Segment-Elevation Myocardial Infarction: DRIVE-STEMI Study.
    Circulation. 2025;151:282-284.
    PubMed    



  216. Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2025;151:e30.
    PubMed    


  217. MAURICIO R, Sharma G, Lewey J, Tompkins R, et al
    Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292.
    PubMed     Abstract available


  218. CHEN JZ, Liang Y, Liang B
    Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
    Circulation. 2025;151:e22.
    PubMed    


  219. SUN M, He S, Hu J, Zhang Y, et al
    Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
    Circulation. 2025;151:e23.
    PubMed    


  220. SIDIQI AW, Dad Zada D, Exeer NA
    Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine.
    Circulation. 2025;151:129-131.
    PubMed    


  221. ROGNE T, Gill D
    Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study.
    Circulation. 2025;151:193-195.
    PubMed    


  222. LIU S, Deshmukh V, Meng F, Wang Y, et al
    Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.
    Circulation. 2025;151:59-75.
    PubMed     Abstract available


  223. CHEW NWS, Mehta A, Goh RSJ, Zhang A, et al
    Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
    Circulation. 2025;151:98-119.
    PubMed     Abstract available


    December 2024
  224. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
    Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
    Circulation. 2024;150:2046-2069.
    PubMed     Abstract available


  225. ZWECK E, Hassager C, Beske RP, Jensen LO, et al
    Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
    Circulation. 2024;150:1990-2003.
    PubMed     Abstract available


  226. BIRKENFELD AL, Franks PW, Mohan V
    Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
    Circulation. 2024;150:1910-1912.
    PubMed    


  227. LEWANDOWSKI AJ, Rutter MK, Collins R
    Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine.
    Circulation. 2024;150:1907-1909.
    PubMed    


  228. JONE PN, Tremoulet A, Choueiter N, Dominguez SR, et al
    Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2024;150:e481-e500.
    PubMed     Abstract available


  229. DENNISON HIMMELFARB CR, Benowitz NL, Blank MD, Bhatnagar A, et al
    Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
    Circulation. 2024 Dec 3. doi: 10.1161/CIR.0000000000001293.
    PubMed     Abstract available


  230. LINDNER JR, Morello M
    In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.
    Circulation. 2024;150:1885-1897.
    PubMed     Abstract available


  231. ARMBRUSTER S, Skali H, Wei LJ
    Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.
    Circulation. 2024;150:1823-1825.
    PubMed    


    November 2024
  232. QIN D, Modanwal R, Kitsis RN
    Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction.
    Circulation. 2024;150:1812-1814.
    PubMed    


  233. ZHANG W, Zhang J, Wang Z, Li T, et al
    Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.
    Circulation. 2024;150:1791-1811.
    PubMed     Abstract available


  234. ITZHAKI BEN ZADOK O, Simitsis P, Jacobson C, Nadeem O, et al
    Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
    Circulation. 2024;150:1815-1817.
    PubMed    


  235. JI Y, Zhang MJ, Wang W, Norby FL, et al
    Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
    Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
    PubMed     Abstract available


  236. MORROW A, Young R, Abraham GR, Hoole S, et al
    Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.
    Circulation. 2024;150:1671-1683.
    PubMed     Abstract available



  237. Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui
    Circulation. 2024;150:e466.
    PubMed    


  238. GIUGNI FR, Berry JD, Khera A, Shah AM, et al
    Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
    Circulation. 2024;150:1720-1731.
    PubMed     Abstract available


  239. HO FK, Mark PB, Lees JS, Pell JP, et al
    A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia.
    Circulation. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454.
    PubMed     Abstract available


  240. GREIF R, Bray JE, Djarv T, Drennan IR, et al
    2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288.
    PubMed     Abstract available


  241. XU X, Zhu H, Xu K
    Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e444.
    PubMed    


  242. LIANG Y, Liang B
    Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e443.
    PubMed    


  243. YAN Y, Nie S, Montalescot G
    Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e445-e446.
    PubMed    


  244. DEZFULIAN C, McCallin TE, Bierens J, Dunne CL, et al
    2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardio
    Circulation. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274.
    PubMed     Abstract available


  245. KIM Y, Landstrom AP, Shah SH, Wu JC, et al
    Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association.
    Circulation. 2024 Nov 11. doi: 10.1161/CIR.0000000000001296.
    PubMed     Abstract available


  246. MA C, Ge J, Han Y
    Global Rounds: Advancing Cardiovascular Health in China.
    Circulation. 2024 Nov 7. doi: 10.1161/CIRCULATIONAHA.124.071544.
    PubMed    


  247. AVERBUCH T, Stelkia K, Van Spall HGC
    Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.
    Circulation. 2024;150:1490-1492.
    PubMed    


  248. BHATIA HS, Wandel S, Willeit P, Lesogor A, et al
    Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
    Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.069556.
    PubMed     Abstract available


  249. DILLON HT, Saner NJ, Ilsley T, Kliman DS, et al
    Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
    Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
    PubMed     Abstract available


    October 2024
  250. VAN DIEPEN S, Poss J, Senaratne JM, Gage A, et al
    Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management.
    Circulation. 2024;150:1459-1468.
    PubMed     Abstract available


  251. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2024;150:1478-1480.
    PubMed    


  252. GRAGNANO F, van Klaveren D, Heg D, Raber L, et al
    Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009.
    PubMed     Abstract available


  253. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, et al
    Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072281.
    PubMed     Abstract available


  254. SELLKE FW
    Bleeding After Cardiovascular Surgery: A Continuing Problem.
    Circulation. 2024;150:1324-1326.
    PubMed    


  255. RUEL M, de Lemos J, Fischbein M, Hill JA, et al
    Introduction to the 2024 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2024;150:1307.
    PubMed    


  256. HOFMANN C, Serafin A, Schwerdt OM, Fischer J, et al
    Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
    Circulation. 2024;150:1248-1267.
    PubMed     Abstract available


  257. SILBERNAGEL G, Chen YQ, Li H, Lemen D, et al
    Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality.
    Circulation. 2024 Oct 11. doi: 10.1161/CIRCULATIONAHA.124.069272.
    PubMed     Abstract available


  258. KRISTENSEN JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, et al
    Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.
    Circulation. 2024;150:1187-1198.
    PubMed     Abstract available


  259. SINNAEVE PR, Welsh RC, Arias Mendoza A, Ristic AD, et al
    Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
    Circulation. 2024;150:1151-1153.
    PubMed    


  260. RUEL M, Chikwe J
    Coronary Artery Bypass Grafting: Past and Future.
    Circulation. 2024;150:1067-1069.
    PubMed    


  261. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
    Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
    Circulation. 2024;150:1101-1120.
    PubMed     Abstract available


    September 2024
  262. ZHAO X, Williamson T, Gong Y, Epstein JA, et al
    Immunomodulatory Therapy for Ischemic Heart Disease.
    Circulation. 2024;150:1050-1058.
    PubMed     Abstract available


  263. DUAN Z, Huang Z, Lei W, Zhang K, et al
    Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics.
    Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.123.065935.
    PubMed     Abstract available


  264. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
    Response by Giacoppo et al to Letter Regarding Article "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
    Circulation. 2024;150:e271-e272.
    PubMed    


  265. ZHANG Z
    Letter by Zhang Regarding Article, "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
    Circulation. 2024;150:e269-e270.
    PubMed    


  266. KOTWAL SS, Perkovic V
    Kidney Disease as a Cardiovascular Disease Priority.
    Circulation. 2024;150:975-977.
    PubMed    


  267. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
    2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001285.
    PubMed     Abstract available


  268. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001289.
    PubMed     Abstract available


  269. LEE DH
    Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants.
    Circulation. 2024;150:908-910.
    PubMed    


  270. SHAH NS, Kandula NR, Commodore-Mensah Y, Morey BN, et al
    Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Sep 16. doi: 10.1161/CIR.0000000000001278.
    PubMed     Abstract available


  271. BUTALA NM, Bucholz EM
    Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained.
    Circulation. 2024;150:836-837.
    PubMed    


  272. BEI Y, Zhu Y, Zhou J, Ai S, et al
    Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.
    Circulation. 2024;150:848-866.
    PubMed     Abstract available


  273. DIWAN A
    The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
    Circulation. 2024;150:787-790.
    PubMed    


  274. WYANT GA, Jiang Q, Singh M, Qayyum S, et al
    Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
    Circulation. 2024;150:770-786.
    PubMed     Abstract available


  275. VOLPP KG
    Using Behavioral Science to Improve Cardiovascular Health.
    Circulation. 2024;150:743-745.
    PubMed    


  276. SIMON T, Herbert BM, Brooks MM, Goodman SG, et al
    Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
    Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.069917.
    PubMed    


  277. CAMPO G, Bohm F, Engstrom T, Smits PC, et al
    Complete vs. Culprit-Only Revascularization in Older Patients with ST-segment Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
    Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071493.
    PubMed     Abstract available


    August 2024
  278. BODEN WE, De Caterina R, Kaski JC, Bairey Merz CN, et al
    Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.123.065656.
    PubMed     Abstract available


  279. NEUEN BL, Fletcher RA, Heath L, Perkovic A, et al
    Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
    PubMed     Abstract available


  280. DEFILIPPIS AP, Abbott JD, Herbert BM, Bertolet MH, et al
    Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
    Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.071208.
    PubMed     Abstract available


  281. BONNESEN K, Heide-Jorgensen U, Christensen DH, Lash TL, et al
    Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.068613.
    PubMed     Abstract available


  282. DELWARDE C, Aikawa M
    Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
    Circulation. 2024;150:706-709.
    PubMed    


  283. LI J, Sun S, Zhu D, Mei X, et al
    Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.
    Circulation. 2024;150:710-723.
    PubMed     Abstract available


  284. YU M, Yang Y, Dong SL, Zhao C, et al
    Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069808.
    PubMed     Abstract available


  285. KERN MJ, Seto AH
    Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results?
    Circulation. 2024;150:598-599.
    PubMed    


  286. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
    Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Circulation. 2024;150:611-621.
    PubMed     Abstract available


  287. KOVILAKATH A, Mauro AG, Valentine YA, Raucci FJ, et al
    SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
    Circulation. 2024;150:622-641.
    PubMed     Abstract available


  288. ABBATE A, Van Tassell B, Bogin V, Markley R, et al
    Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
    Circulation. 2024;150:580-582.
    PubMed    


  289. MOSLEHI JJ
    Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
    Circulation. 2024;150:513-515.
    PubMed     Abstract available


  290. MORRIS SA, Flyer JN, Yetman AT, Quezada E, et al
    Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Aug 12. doi: 10.1161/CIR.0000000000001265.
    PubMed     Abstract available


  291. LIN Y, Gil CH, Banno K, Yokoyama M, et al
    ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
    Circulation. 2024;150:451-465.
    PubMed     Abstract available


  292. BITTNER V
    Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
    Circulation. 2024;150:435-438.
    PubMed    


  293. JOYNT MADDOX KE
    Health Economics of Cardiovascular Disease in the United States.
    Circulation. 2024;150:419-421.
    PubMed    


  294. MARTINEZ-MORATA I, Schilling K, Glabonjat RA, Domingo-Relloso A, et al
    Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.124.069414.
    PubMed     Abstract available


    July 2024

  295. Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;150:e105.
    PubMed    


  296. VALGIMIGLI M, Landi A, Angiolillo DJ, Baber U, et al
    Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.
    Circulation. 2024;150:317-335.
    PubMed     Abstract available


  297. ARMSTRONG PW
    Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
    Circulation. 2024;150:258-260.
    PubMed    


  298. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
    Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
    Circulation. 2024;150:250-252.
    PubMed    


  299. WANG Y, Chen GC, Wang Z, Luo K, et al
    Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
    Circulation. 2024;150:215-229.
    PubMed     Abstract available


  300. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2024;150:243-245.
    PubMed    


  301. ADEDINSEWO D
    Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
    Circulation. 2024;150:174-176.
    PubMed    


  302. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
    Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
    Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
    PubMed     Abstract available


  303. ABBARA S, Shaw LJ
    Past, Present, and Future of CTA.
    Circulation. 2024;150:87-90.
    PubMed    


  304. FLEG JL, Huang Z, Reynolds HR, Shaw LJ, et al
    Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
    Circulation. 2024;150:165-167.
    PubMed    


  305. KUEHN BM
    Million Hearts Model Reduces Cardiovascular Events Without Increasing Care Costs.
    Circulation. 2024;150:162-164.
    PubMed    


  306. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
    Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
    Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
    PubMed     Abstract available


  307. BERRY C, Sidik NP, McEntegart MB
    Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
    Circulation. 2024;150:e5-e6.
    PubMed    


  308. NISHI T, Saito Y, Kobayashi Y
    Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
    Circulation. 2024;150:e3-e4.
    PubMed    


    June 2024
  309. KIM K, Joyce BT, Zheng Y, Nannini DR, et al
    Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.123.067992.
    PubMed     Abstract available


  310. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
    Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
    PubMed     Abstract available


  311. LIU T, Hao Y, Zhang Z, Zhou H, et al
    Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
    Circulation. 2024;149:2002-2020.
    PubMed     Abstract available


  312. JHA AK
    Letter by Jha Regarding Article, "Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial".
    Circulation. 2024;149:e1415-e1416.
    PubMed    


  313. ZHANG S, Zhang Y, Duan X, Wang B, et al
    Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism.
    Circulation. 2024;149:1982-2001.
    PubMed     Abstract available


  314. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
    Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
    Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
    PubMed     Abstract available


  315. MIYAUCHI K, Iwata H, Nishizaki Y, Inoue T, et al
    Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
    Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520.
    PubMed     Abstract available



  316. Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1411.
    PubMed    


  317. HUNDLEY WG
    Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis.
    Circulation. 2024;149:1859-1861.
    PubMed    


  318. ANDREOTTI F, Burzotta F, Maggioni AP
    Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".
    Circulation. 2024;149:e1312.
    PubMed    


  319. GURAGAIN B, Wei Y, Zhang H, Kahn-Krell A, et al
    Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium.
    Circulation. 2024;149:1855-1857.
    PubMed    


  320. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
    Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
    PubMed     Abstract available


  321. MORAN AE, Goldman L
    Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown.
    Circulation. 2024 Jun 4. doi: 10.1161/CIRCULATIONAHA.124.070265.
    PubMed    


  322. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
    PubMed     Abstract available


    May 2024
  323. MEHTA LS, Churchwell K, Coleman D, Davidson J, et al
    Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association.
    Circulation. 2024 May 30. doi: 10.1161/CIR.0000000000001259.
    PubMed     Abstract available


  324. NAKAMORI S, Amyar A, Fahmy AS, Ngo LH, et al
    Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
    Circulation. 2024 May 29. doi: 10.1161/CIRCULATIONAHA.123.067107.
    PubMed     Abstract available


  325. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
    Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
    Circulation. 2024;149:1729-1748.
    PubMed     Abstract available


  326. ZHAI X, Cao S, Wang J, Qiao B, et al
    Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
    Circulation. 2024;149:1752-1769.
    PubMed     Abstract available



  327. Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1218.
    PubMed    


  328. SATTAR N, Neeland IJ, McGuire DK
    Obesity and Cardiovascular Disease: A New Dawn.
    Circulation. 2024;149:1621-1623.
    PubMed    


  329. ZHU Q, Scherer PE
    Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
    Circulation. 2024;149:1624-1626.
    PubMed    


  330. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
    Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
    PubMed     Abstract available


  331. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
    Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
    PubMed     Abstract available



  332. Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
    Circulation. 2024;149:e1189-e1190.
    PubMed    


  333. TANG WHW, Hazen SL
    Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
    Circulation. 2024;149:1543-1545.
    PubMed    


  334. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
    Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
    Circulation. 2024;149:1536-1539.
    PubMed    


    April 2024
  335. KELHAM M, Mathur A, Jones DA
    Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1133.
    PubMed    


  336. APOSTOLOS A, Karamasis GV, Tsigkas G
    Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1132.
    PubMed    


  337. ZAMAN S, Edwards NC, Chew DP
    Global Rounds: Cardiovascular Care in Australia and New Zealand.
    Circulation. 2024;149:1402-1404.
    PubMed    


  338. SOLOMON CG, Landrigan PJ
    Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
    Circulation. 2024;149:1400-1401.
    PubMed    


  339. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
    Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
    Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
    PubMed     Abstract available


  340. GIRI J, Kaneko T
    Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
    Circulation. 2024;149:1339-1340.
    PubMed    


  341. SHAH SH, Gerszten RE
    Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
    Circulation. 2024;149:1323-1325.
    PubMed    


  342. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
    Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
    Circulation. 2024;149:1341-1353.
    PubMed     Abstract available



  343. Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1128.
    PubMed    


  344. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
    Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
    PubMed     Abstract available


  345. PATEL SM, Kang YM, Im K, Neuen BL, et al
    Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
    PubMed     Abstract available


  346. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
    PubMed     Abstract available


  347. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
    Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
    PubMed     Abstract available


  348. CHO L, Plutzky J, Brennan D, Louie MJ, et al
    Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
    PubMed    


  349. MAEHARA A, Sugizaki Y
    Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
    Circulation. 2024;149:1087-1089.
    PubMed    


  350. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
    Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1051-e1065.
    PubMed     Abstract available


  351. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
    Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
    Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
    PubMed    


    March 2024
  352. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
    Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
    PubMed     Abstract available


  353. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
    Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
    Circulation. 2024;149:1033-1052.
    PubMed     Abstract available


  354. SERRUYS PW, Revaiah PC
    The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
    Circulation. 2024;149:973-978.
    PubMed    


  355. FENG J, Li Y, Li Y, Yin Q, et al
    Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
    Circulation. 2024;149:1004-1015.
    PubMed     Abstract available



  356. Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2024;149:e1023.
    PubMed    


  357. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
    Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
    Circulation. 2024;149:1056-1058.
    PubMed    


  358. TENG Z, Ma Y, Ma X
    Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e960-e961.
    PubMed    


  359. FRANGOGIANNIS NG
    Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e962-e963.
    PubMed    


  360. MARANO P, Mouapi K, Kim A, Mastali M, et al
    Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
    Circulation. 2024;149:970-972.
    PubMed    


  361. EVERETT BM
    The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
    Circulation. 2024;149:914-916.
    PubMed    


  362. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
    A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
    Circulation. 2024;149:902-904.
    PubMed    


  363. JUNCA G, Delgado V
    Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
    Circulation. 2024;149:822-824.
    PubMed    


  364. HEUTS S, Myers PO, Siepe M
    Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:892-893.
    PubMed    


  365. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
    Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:894-895.
    PubMed    


  366. ZIMMERMANN FM, Ding VY, Fearon WF
    Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:896.
    PubMed    


  367. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
    Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
    PubMed     Abstract available


  368. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
    Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
    Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
    PubMed     Abstract available


  369. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
    The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
    Circulation. 2024;149:732-733.
    PubMed    


  370. RAJAGOPALAN S, Brook RD
    Cardiovascular and Planetary Health: Two Sides of the Same Planet.
    Circulation. 2024;149:729-731.
    PubMed    


    February 2024
  371. CHEN Z, Zhang J, He Y
    Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:725-726.
    PubMed    


  372. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
    Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:727-728.
    PubMed    


  373. GAFFEY AE, Rollman BL, Burg MM
    Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
    Circulation. 2024;149:641-643.
    PubMed    


  374. DZAU VJ, Hodgkinson CP
    RNA Therapeutics for the Cardiovascular System.
    Circulation. 2024;149:707-716.
    PubMed     Abstract available


  375. YAN Y, Guo J, Wang X, Wang G, et al
    Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
    Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
    PubMed     Abstract available


    October 2023
  376. GAUDINO M, Sandner S, An KR, Dimagli A, et al
    Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
    Circulation. 2023;148:1305-1315.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum